
JPMorgan says Nvidia holds 39% of future frontier AI lab compute deals, down from over 80% in 2023-2025, as its off-balance-sheet obligations doubled to $422 billion.
In brief
What happened
JPMorgan
JPM says Nvidia
NVDA now holds 39% of future frontier AI lab compute deals, according to Coin Bureau.
That compares with a market share above 80% from 2023 to 2025.
The rest of those deals go to Broadcom
AVGO custom chips at 24%, Google TPUs at 16%, AMD at 15% and Amazon
AMZN Trainium at 6%, per the same note.
Coin Bureau also reports that one frontier lab says moving its models to AMD chips now takes three days instead of 6 to 12 months.
Of the seven biggest AI chip buyers, only SpaceX is not trying to build its own, the note says.
Nvidia
NVDA spent 58% of its operating cash flow on equity investments and acquisitions over the last three quarters.
Its off-balance-sheet obligations jumped from $214 billion to $422 billion in a single quarter.
Baird cut its price target from $500 to $200, according to the same post.
Why it matters
The note landed two days after Jensen Huang resigned as chief executive on 12 November, according to Coin Bureau.
Nvidia
NVDA shares have already rebounded above $170, up +15% from the low after his resignation, as investors bought the dip, our earlier market post reported.
Two investors with over $2 billion have urged the board to reinstate Huang, a push covered here.
A smaller share of frontier deals and a larger pile of off-balance-sheet obligations change how holders read the company's growth story.
China remains a separate pressure point.
Reuters identified more than $3.2 billion in Chinese AI projects specifying Nvidia
NVDA chips subject to US export controls, though the figure covers total project investment, not confirmed chip purchases, Decrypt reported.
Culper Research said six months ago it was short NVDA over a "China problem", and the stock has since fallen more than 25%, erasing $1.5 trillion in market value, our post on that call noted.
What to watch
Nvidia
NVDA earnings are expected in a window from 16 November to 5 December, according to our calendar.
The results will be the first test of how investors weigh the JPMorgan
JPM figures against the post-resignation rebound.